James R Stubbs

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Transfusion-related acute lung injury, an evolving syndrome: the road of discovery, with emphasis on the role of the Mayo Clinic
    James R Stubbs
    Mayo Clinic, Rochester, Rochester, MN, USA
    Transfus Med Rev 25:66-75. 2011
  2. doi request reprint Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions
    Jeffrey L Winters
    Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Transfusion 50:1444-52. 2010
  3. doi request reprint The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis
    Mohammad Hassan Murad
    Knowledge and Encounter Research Unit, the Division of Preventive Medicine, and the Department of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Transfusion 50:1370-83. 2010
  4. ncbi request reprint Perioperative coagulation management--fresh frozen plasma
    Daryl J Kor
    Department of Anesthesiology Division of Critical Care Medicine Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Best Pract Res Clin Anaesthesiol 24:51-64. 2010
  5. ncbi request reprint Alternatives to blood product transfusion in the critically ill: erythropoietin
    James R Stubbs
    Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Crit Care Med 34:S160-9. 2006

Collaborators

Detail Information

Publications5

  1. doi request reprint Transfusion-related acute lung injury, an evolving syndrome: the road of discovery, with emphasis on the role of the Mayo Clinic
    James R Stubbs
    Mayo Clinic, Rochester, Rochester, MN, USA
    Transfus Med Rev 25:66-75. 2011
    ..The common thread connecting the Mayo Clinic's descriptions in the 1980s to the more contemporary studies is Dr S. Breanndan Moore. Dr Moore passed away recently, but his crucial work in the area of TRALI lives on...
  2. doi request reprint Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions
    Jeffrey L Winters
    Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Transfusion 50:1444-52. 2010
    ..In June 2003, a gel microcolumn technique was implemented. Impact of this on antibody detection and DHTR and DSTR incidence was investigated...
  3. doi request reprint The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis
    Mohammad Hassan Murad
    Knowledge and Encounter Research Unit, the Division of Preventive Medicine, and the Department of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Transfusion 50:1370-83. 2010
    ..We systematically reviewed the literature to summarize the available evidence regarding the benefits and harms of plasma transfusion in common clinical settings...
  4. ncbi request reprint Perioperative coagulation management--fresh frozen plasma
    Daryl J Kor
    Department of Anesthesiology Division of Critical Care Medicine Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Best Pract Res Clin Anaesthesiol 24:51-64. 2010
    ..Both provide an opportunity for increasing the safe plasma donor pool. Although prothrombin complex concentrates and factor VIIa may be used as alternatives to FFP in a variety of specific clinical contexts, additional study is needed...
  5. ncbi request reprint Alternatives to blood product transfusion in the critically ill: erythropoietin
    James R Stubbs
    Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Crit Care Med 34:S160-9. 2006
    ..To present information regarding the use of recombinant human erythropoietin (rHuEPO) to treat anemia in intensive care unit (ICU) patients..